ClinicalTrials.gg
RecruitingNCT06854731ACTIVEUpdated Sep 9, 2026

Preventing Falls in Older Adults With Cognitive Frailty

An interventional study of Balance and Strength Training Exercises with Health Coaching and Education Session in Falls, Frailty and Mild Cognitive Impairment, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to participants aged 65 Years to 89 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by University of British Columbia · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
328
Allocation
Randomized
Ages
65 Years to 89 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 83 studies in Frailty with a site in Canada — 23 open to participants now, 34 under way, none of them phase 3. Frailty · Canada.

Planned enrollment
10th of 60
328 · median 80
Started
2025
with 7 others
No phase
58 of 83
16 open now
Primary completion
2029-05
later than 32 of 33 live
Registered
78th of 83
by date
Lead sponsor
4 of 83
University of British Columbia

Among the 83 studies in Frailty with a site in Canada, this one is the 10th largest by planned enrollment of the 60 interventional ones that give a count, is one of 8 that started in 2025, is one of 58 with no phase, reaches primary completion later than 32 of the 33 other live ones, and was the 78th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

23 of the 83 studies in Frailty with a site in Canada are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 65 Years to 89 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 83 studies in Frailty with a site in Canada, or all of them as a file.
02

Study summary

The Problem: The proposed trial will address the problem of how to effectively prevent subsequent falls in community-dwelling cognitively frail older adults with a history of falls.

Primary Question: In community-dwelling older adults with cognitive frailty and a history of falls, can a home-based exercise program with behavioural change techniques significantly reduce falls vs. health education (i.e., control; CON)?

Read the detailed description

Rationale: Falls are a significant cause of functional decline and often a sentinel event. Older adults with cognitive frailty - those with concurrent physical frailty and mild cognitive impairment - are at particular risk for falls. Notably, falls can cause a sudden and severe change in their health state from one of independence to one of dependence. Thus, effective falls prevention strategies need to be identified for older adults with cognitive frailty.

The Otago Exercise Program (OEP) - a physical therapist (PT) delivered home-based exercise program - is an evidence-based falls prevention program for community-dwelling older adults. Our pilot data show the OEP vs. usually care significantly reduced subsequent falls in 192 community-dwelling older adults with cognitive frailty and a history of falls; the incident rate ratio was 0.64 (95% CI, 0.43-0.98; P = .042). These preliminary findings need to be confirmed in a rigorously designed RCT powered for falls in older adults with cognitive frailty; none exist to date.

We also observed lower OEP adherence among older adults with cognitive frailty vs. those without cognitive frailty. Thus, strategies to support adherence must be considered in RCTs of exercise to prevent falls in this high-risk population. Evidence-based strategies include health coaching.

Thus, we propose a 12-month multi-site randomized controlled trial (RCT) in older adults with cognitive frailty and a history of falls to assess the efficacy of the OEP combined with health coaching (i.e., OEP+) to prevent falls.

Primary Question: In community-dwelling older adults with cognitive frailty and a history of falls, can the OEP+ significantly reduce falls vs. health education (i.e., control; CON)?

Secondary Questions: 1) What are additional benefits of the OEP+ vs. CON? 2) Do the benefits of OEP+ persist 6 months post cessation? 3) Can the OEP+ reduce falls or improve quality of life at similar or lower costs vs. CON?

Methods: A 12-month assessor-blinded, multi-site RCT, with a 6-month follow-up, in older adults, with cognitive frailty - defined by a Short Physical Performance Battery score \<= 9/12 and a Montreal Cognitive Assessment score between 18-25/30 - and a history of falls. Participants will be randomized to either: a) OEP+ or b) CON. The OEP+ intervention will include Brief Action Planning-based health coaching. The CON group will include monthly interactive education sessions via Zoom. Measurement will occur at baseline, 6, 12, and 18 months, with falls tracked daily.

03

Conditions studied

  • Falls
  • Frailty
  • Mild Cognitive Impairment

Keywords

  • execise
  • falls
  • cognitive frailty
04

Who can participate

Ages eligible
65 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

We will include individuals who meet the following criteria: 1) aged between 65 and 89 years; 2) live in Greater Vancouver, British Columbia; 3) are community-dwelling (i.e., not residing in a nursing home or extended care unit); 4) experienced a non-syncopal fall in the prior 12 months; 5) scored ≤ 9/12 on the SPPB; 6) have subjective cognitive impairment based on interview; 7) scored 18-25/30 on the [62,64]; 8) are able to walk with or without a gait aid; 9) scored ≥ 6/8 on Lawton and Brody Instrumental Activities of Daily Living Scale (IADL) [65]; 10) are able to safely engage in exercise as indicated by the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) [66]; and 11) are able to understand, speak, and read English with sufficient proficiency to complete the assessments.

*The age maximum of 89 was set due to the increased risk of significant adverse health outcomes cognitively frail older adults face. As this population has an increased risk of falls, functional disability with loss of independence, hospitalization, and death, setting an age maximum aims to increase the likelihood that participants will be able to complete the 18-month study without interruptions due to health complications. This age limit has been reviewed and approved by CIHR.

Exclusion criteria

Exclusion Criteria:

We will exclude individuals who: 1) have been diagnosed with dementia, a neurodegenerative disease, or stroke; 2) report engaging in strength and balance training exercises ≥ 2 times per week in the prior 3 months; 3) have severe depression based on a score of ≥ 11/15 on the GDS.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
328 participants (estimated)

Study arms

  • Active comparator
    Educational Control

    All active control participants will be invited to join monthly interactive education sessions via Zoom or in-person.

    Other: Education Session

  • Experimental
    Otago Exercise Program (OEP) Plus

    The OEP+ intervention integrates the OEP with health coaching by a physical therapist or kinesiologist. The OEP is an individualized home-based balance and strength exercise training program delivered by a PT or kinesiologist coach over 5 home visits and 6 phone check-ins

    Behavioral: Balance and Strength Training Exercises with Health Coaching

Interventions

  • BehavioralBalance and Strength Training Exercises with Health Coaching

    The OEP+ intervention integrates the OEP with health coaching by a physical therapists or kinesiologist. The OEP is an individualized home-based balance and strength exercise training program delivered by a PT or kinesiologist coach over 5 home visits.

    Also known as: Otago Exercise Program Plus (OEP+)

  • OtherEducation Session

    All active comparator participants will be invited to join monthly interactive social and education sessions via Zoom or in-person (hybrid delivery).

06

What researchers measure

Primary outcomes

  1. Falls

    The number of self-reported falls during the 12-month intervention period (i.e., rate of falls).

    Time frame: Daily tracking over 12 months

Secondary outcomes

  1. Short Physical Performance Battery

    A physical performance battery out of 12 points (max. performance).

    Time frame: Baseline, 6 months, 12 months, 18 months

  2. Montreal Cognitive Assessment

    A test that covers multiple cognitive domains. Often used to screen for mild cognitive impairment.

    Time frame: Baseline, 6 months, 12 months, 18 months

  3. Falls during followup period

    The number of self-reported falls during the 6-month ifollowup period (i.e., rate of falls).

    Time frame: Daily tracking from 12 months (trial completion) to end of 6-month followup (18 months)

  4. NIH Cognitive Toolbox

    Cognitive function measured using the NIH Cognitive Toolbox: Dimensional Change Card Sort Test and Flanker Inhibitory Control and Attention Test

    Time frame: Baseline, 6 months, 12 months, 18 months

  5. Processing speed

    Processing speed measured by Digit Symbol Substitution Test

    Time frame: Baseline, 6 months, 12 months, 18 months

  6. Memory

    Memory measured by the Rey Auditory Verbal Learning Test

    Time frame: Baseline, 6 months, 12 months, 18 months

  7. Gait Speed

    Walking speed in m/s measured over 4 meters (part of the Short Physical Performance Battery)

    Time frame: Baseline, 6 months, 12 months, 18 months

  8. Muscle Strength

    Dominant quadriceps strength and dominant hand grip strength.

    Time frame: Baseline, 6 months, 12 months, 18 months

  9. Community Mobility

    Life Space Questionnaire to measure community mobility

    Time frame: Baseline, 6 months, 12 months, 18 months

  10. Functional Mobility

    Timed Up and Go Test to measure functional mobility

    Time frame: Baseline, 6 months, 12 months, 18 months

  11. Fatigue

    The 9-item Fatigue Severity Scale will be used to assess how fatigue interferes with certain activities and its severity.

    Time frame: Baseline, 6 months, 12 months, 18 months

  12. Quality of Life

    The EuroQol EQ-5 Domain (5D)-5 Level (5L) (EQ-5D-5L) and the EuroQol Visual Analogue Scale (EQ-VAS) will assess quality of life

    Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 18 months

  13. Fear of Falling

    Fear of falling as assessed by the Iconographical Falls Efficacy Scale (Icon-FES).

    Time frame: Baseline, 6 months, 12 months, 18 months

  14. Health Resource Utilization (HRU)

    Cost data will be collected every 3 months using the HRU questionnaire

    Time frame: Baseline, 3 months, 6 months, 9 months, 12 months, 18 months

  15. Sleep Quality (Objective) - Optional

    Sleep quality parameters will be measured using ActiGraph

    Time frame: Baseline, 6 months, 12 months, 18 months

  16. Brain Function - Optional

    Brain function will be measured using functional near-infrared spectroscopy

    Time frame: Baseline, 6 months, 12 months

  17. Physical Frailty

    The Short Physical Performance Battery (physical performance battery out of 12 points (max. performance) and the Fried Frailty Phenotype (scores range from 0-5 where 0 is characterized as non-frail, 1-2 as pre-frail and \>=3 as frail)

    Time frame: Baseline, 6 months, 12 months, 18 months

  18. Physical Activity

    The Physical Activity Scale for the Elderly (PASE) will be used to measure physical activity levels. PASE is a 12-item scale.

    Time frame: Baseline, 6 months, 12 months, 18 months

  19. Mood

    15-item Geriatric Depression Scale (GDS) will be used to assess depressive symptoms. GDS score of \>=11/15 is suggestive of severe depression

    Time frame: Baseline, 6 months, 12 months, 18 months

  20. Fall Risk

    Fall risk is assessed by the Physiological Profile Assessment (PPA). A PPA z-score of 0-1 is indicative of mild fall risk, 1-2 indicates moderate risk, 2-3 indicates high risk, and \> 3 indicates marked risk

    Time frame: Baseline, 6 months, 12 months, 18 months

  21. Frailty Index

    A frailty index will be calculated based on an accumulation of deficits across multiple domains and constructed using our primary and secondary outcome measures.

    Time frame: Baseline, 6 months, 12 months, 18 months

07

Study locations

1 of 1 sites recruiting
  • Centre for Aging SMART at VCH, University of BC
    Vancouver, British Columbia V5Z1M9, Canada
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for May 2029, 47 months after the start.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 47 months is above that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 17, 2025
First posted
Mar 3, 2025
StartActual
May 15, 2025
Primary completionEst.
May 1, 2029
CompletionEst.
Dec 31, 2029
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06854731
Collaborators
Vancouver Coastal Health Research Institute
Responsible party
Teresa Liu-Ambrose (Professor, University of British Columbia) — Principal investigator
First posted
Mar 3, 2025
Start date
May 15, 2025
Primary completion
May 1, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Sep 9, 2026

Study contacts

Teresa Liu-Ambrose, PhD
Contact
teresa.ambrose@ubc.ca
6046178047
Teresa Liu-Ambrose, PhD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion